Vivo Bio Tech Limited (BOM:511509)
India
· Delayed Price · Currency is INR 27.83
+0.57 (2.09%)
At close: Apr 29, 2026
Vivo Bio Tech Cash Flow Statement
Financials in millions INR. Fiscal year is April - March.
Millions INR. Fiscal year is Apr - Mar.
Fiscal Year | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 | 2020 - 2016 |
|---|---|---|---|---|---|---|---|
Period Ending | Dec '25 Dec 31, 2025 | Mar '25 Mar 31, 2025 | Mar '24 Mar 31, 2024 | Mar '23 Mar 31, 2023 | Mar '22 Mar 31, 2022 | Mar '21 Mar 31, 2021 | 2020 - 2016 |
| Net Income | - | 72.83 | 25.26 | 26.49 | 22.02 | 56.82 | Upgrade
|
| Depreciation & Amortization | - | 69.3 | 71.98 | 71.68 | 59.32 | 46.9 | Upgrade
|
| Other Amortization | - | 20.86 | 20.93 | 20.97 | 15.14 | 9.02 | Upgrade
|
| Loss (Gain) From Sale of Assets | - | -46.15 | - | - | - | - | Upgrade
|
| Other Operating Activities | - | 54.68 | 62.53 | 62.84 | 28.11 | - | Upgrade
|
| Change in Accounts Receivable | - | 52.33 | -154.26 | -61.55 | 12.51 | 15.33 | Upgrade
|
| Change in Accounts Payable | - | -105.57 | 128.78 | 27.9 | 29.32 | 13.69 | Upgrade
|
| Operating Cash Flow | - | 118.28 | 155.22 | 148.34 | 166.42 | 141.76 | Upgrade
|
| Operating Cash Flow Growth | - | -23.80% | 4.64% | -10.87% | 17.40% | 64.69% | Upgrade
|
| Capital Expenditures | - | -222.7 | -79.5 | -39.98 | -511.12 | -228.22 | Upgrade
|
| Sale of Property, Plant & Equipment | - | 64.29 | - | - | - | - | Upgrade
|
| Investing Cash Flow | - | -158.42 | -79.5 | -39.98 | -511.12 | -228.22 | Upgrade
|
| Long-Term Debt Issued | - | - | - | - | 354.29 | 49.62 | Upgrade
|
| Long-Term Debt Repaid | - | -68.5 | -13.04 | -69.87 | - | - | Upgrade
|
| Net Debt Issued (Repaid) | - | -68.5 | -13.04 | -69.87 | 354.29 | 49.62 | Upgrade
|
| Issuance of Common Stock | - | 89.51 | - | 27.86 | 31.37 | 38.21 | Upgrade
|
| Other Financing Activities | - | 18.04 | -62.53 | -69.74 | -35.48 | - | Upgrade
|
| Financing Cash Flow | - | 39.05 | -75.57 | -111.75 | 350.18 | 87.83 | Upgrade
|
| Miscellaneous Cash Flow Adjustments | - | - | - | - | 0 | - | Upgrade
|
| Net Cash Flow | - | -1.09 | 0.15 | -3.39 | 5.48 | 1.37 | Upgrade
|
| Free Cash Flow | - | -104.42 | 75.72 | 108.36 | -344.7 | -86.46 | Upgrade
|
| Free Cash Flow Growth | - | - | -30.12% | - | - | - | Upgrade
|
| Free Cash Flow Margin | - | -22.37% | 16.66% | 20.75% | -67.07% | -16.70% | Upgrade
|
| Free Cash Flow Per Share | - | -6.83 | 4.54 | 7.31 | -24.34 | -6.38 | Upgrade
|
| Cash Interest Paid | - | 75.04 | 77.78 | 76.51 | 39.93 | 35.3 | Upgrade
|
| Cash Income Tax Paid | - | 15.1 | 15.34 | 19.72 | 22.71 | 29.37 | Upgrade
|
| Levered Free Cash Flow | - | -34.6 | -105.99 | 18.8 | -390.38 | -122.77 | Upgrade
|
| Unlevered Free Cash Flow | - | 12.3 | -57.37 | 66.62 | -365.42 | -100.71 | Upgrade
|
| Change in Working Capital | - | -53.24 | -25.48 | -33.65 | 41.83 | 29.02 | Upgrade
|
Source: S&P Capital IQ. Standard template. Financial Sources.